Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Roambee, the Silicon Valley-headquartered global supply chain visibility provider announces its second acquisition, Modum, a European pharma last mile-focused cold chain monitoring player based in Zurich, Switzerland. This acquisition will enable ...
read more
RLS Radiopharmacies, the only Joint Commission-accredited radiopharmacy network in the U.S., announced it is expanding its business operations with the addition of radiopharmaceutical contract development and manufacturing (rCDMO) services.
read more
Thursday, September 25, 2025
The Ritedose Corporation is investing more than $17M to further its in-house cGMP laboratory capabilities by expanding its analytical chemistry and microbiology laboratories.
read more
The Ritedose Corporation, a pharmaceutical manufacturer specializing in Blow-Fill-Seal (BFS) technology, unveiled its new distribution and logistics facility at Performance Park during a ribbon-cutting ceremony. The grand opening event included ...
read more
Tuesday, January 21, 2025
In response to the growing demand for skilled professionals in South Carolina's life sciences sector, The Ritedose Corporation has partnered with Newberry College to launch a new Pharmaceutical Manufacturing program, set to begin in the summer of ...
read more
Rising Pharmaceuticals announced the U.S. launch & commercial shipment of a generic version of Lyrica®, (pregabalin) Capsules, in all eight commercially available strengths.
read more
Tuesday, September 23, 2025
RION, a commercial and clinical-stage regenerative medicine company pioneering platelet-derived exosomes for both human and animal health applications, has announced a collaboration with Lonza, to provide cGMP manufacturing and technical support for ...
read more
Wednesday, January 04, 2017
Rinchem Company Inc., announces the opening of a new facility in the Atlanta metro area. The warehouse, located at 3195 N. Lanier Parkway in Decatur, Georgia, has 80,000 square feet of storage space.
read more
Wednesday, January 23, 2019
Rigel has entered into an exclusive license and supply agreement with Grifols to commercialize fostamatinib disodium hexahydrate in all potential indications in Europe and Turkey.
read more
Tuesday, February 02, 2021
Rigel has been awarded $16.5 million by the U.S. DOD to support Rigel's ongoing Phase 3 clinical trial to evaluate the safety and efficacy of fostamatinib in hospitalized COVID-19 patients.
read more
Rigel has entered into an exclusive license and supply agreement with Kissei to develop and commercialize Tavalisse in all current and potential indications in Japan, China, Taiwan and Korea.
read more
Richman Chemical, Inc. today announced a new Consulting Services Division to assist chemistry-based startups with evaluating new technologies and establishing strategic relationships with service providers, regulatory experts, technology licensing ...
read more
Richman Chemical Inc. (RCI), a custom synthesis, chemical manufacturing, and raw materials sourcing provider to the life science and chemical industries, announces a new partnership with Auditweaver, LLC., a specialty consultancy firm to the life ...
read more
Monday, November 04, 2013
Almac’s Clinical Services Business Unit is delighted to announce that Richard Segiel, Jr. has joined the company as Vice President of Business Development for the United States. He brings with him 23 successful years of experience in the contract ...
read more
Chiltern, a global clinical research organization, announced that Richard Pilnik has been named chairman. In 2015, he joined the Chiltern board of directors and has made significant contributions to the company’s strategy and future direction. Pilnik...
read more